Skip to content

Effect of Acute Protein Supplementation in Diabetic Patients

Effect of House Cricket Preload on Glycemic Response in Type 2 Diabetes Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06880614
Enrollment
20
Registered
2025-03-17
Start date
2025-06-01
Completion date
2025-12-01
Last updated
2025-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus Type 2

Brief summary

The goal of this trial is to test the effect of house cricket (Acheta domesticus) preload on glycemic response in diabetic patients. The main question\[s\] it aims to answer are: whether house cricket powder could lower blood glucose spike and stimulate higher insulin response. Participants will consume either house cricket powder, whey protein isolate or placebo which will be mixed with a chicken-flavored soup. Participants fingers will be pricked for up to 2 hours. Researcher will compare house cricket powder with placebo to see if the glycemic response is better in house cricket supplemented group. Researcher will compare house cricket powder with whey protein isolate to see if both supplement induce comparable glycemic response.

Detailed description

Participants blood will be collected at 8 time points: Baseline 20 minutes after pre load 15 minutes after Oral Glucose Tolerance Test (OGTT) 30 minutes after OGTT 45 minutes after OGTT 60 minutes after OGTT 90 minutes after OGTT 120 minutes after OGTT

Interventions

The participants are required to drink a glucose solution containing 75 g of glucose dissolved in 250 mL of water

DIETARY_SUPPLEMENTWhey

Supplemented with whey protein isolate masked with a chicken-flavored soup

DIETARY_SUPPLEMENTHouse cricket

Supplemented with house cricket powder masked with chicken-flavored soup

DIETARY_SUPPLEMENTPlacebo

Placebo consists of chicken-flavored soup without any supplement inside

Sponsors

University of Malaya
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Caregiver, Investigator)

Intervention model description

Randomized, Cross over, Controlled Trial

Eligibility

Sex/Gender
MALE
Healthy volunteers
No

Inclusion criteria

* Suffering from type 2 diabetes mellitus (HbA1c \> 6.5%) * Consume metformin for at least 6 months

Exclusion criteria

* Consume other type of anti-diabetic drugs * Presenting any food allergy * Recent surgery or infections that may affect oral glucose tolerance test * Consume other drugs that may affect oral glucose tolerance test * Not consuming any anti-diabetic drugs * Pre-diabetes (HbA1c 5.7 - 6.4%)

Design outcomes

Primary

MeasureTime frameDescription
Blood glucose120 minutesBlood glucose concentration measured using glucometer. Participants fingers are pricked and using capillary tube, a drop of the blood is dripped in a test strip before inserted to a glucometer.

Secondary

MeasureTime frameDescription
Blood insulin120 minutesBlood sample is collected through a finger prick. The blood will be centrifuged to obtain the serum. Insulin serum concentration is then measured by using ELISA kits. The blood sample are treated following the kit guideline, and the insulin concentration are measured by comparing the light absorbance against a prepared standard.

Countries

Malaysia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026